NATURES SUNSHINE PRODUCTS INC 8-K
Research Summary
AI-generated summary
Nature’s Sunshine Products Reports Q1 2026 Results; Adopts 2026 Stock Plan
What Happened
- Nature’s Sunshine Products, Inc. filed an 8‑K on May 7, 2026 announcing its financial results for the quarter ended March 31, 2026 (press release dated May 6, 2026, attached as Exhibit 99.1).
- At its May 6, 2026 Annual Meeting, shareholders re-elected all board nominees, ratified Deloitte & Touche LLP as auditor for 2026, and approved the Company’s 2026 Stock Incentive Plan, which became effective May 6, 2026.
Key Details
- Earnings disclosure: Q1 2026 results were announced via press release (quarter ended March 31, 2026); details in Exhibit 99.1.
- 2026 Stock Incentive Plan: authorizes up to 1,500,000 shares of common stock for issuance; effective May 6, 2026; eligible recipients include employees, officers, consultants and non‑employee directors; award types include stock options, SARs, restricted stock/RSUs, performance awards, dividend equivalents and other stock‑based awards.
- Shareholder votes (selected):
- Election of directors: all nominees elected (examples: Steven Fasching — For 13,775,074; Curtis Kopf — For 13,735,217; Katie May — For 13,788,255). Broker non‑votes: 1,286,995 on director elections.
- Advisory vote on executive compensation (say‑on-pay): For 11,288,205; Against 779,056; Abstain 1,864,053; Broker non‑votes 1,286,995.
- Ratification of Deloitte & Touche LLP as auditor: For 14,619,306; Against 566,274; Abstain 32,729 (no broker non‑votes).
- Approval of 2026 Stock Incentive Plan: For 6,357,245; Against 5,723,107; Abstain 1,850,962; Broker non‑votes 1,286,995.
Why It Matters
- The press release with Q1 2026 results provides the most recent quarterly earnings and financial condition update for investors to assess near‑term performance.
- The approved 2026 Stock Incentive Plan allows the company to grant up to 1.5 million shares in various equity forms, which can affect future share count and executive compensation alignment; investors should watch for future grant disclosures that could dilute shares.
- Board continuity (all directors re‑elected) and auditor ratification (Deloitte) signal governance stability.
Loading document...